1h Free Analyst Time
The womens health diagnostics market is forecasted to grow by USD 14.60 billion during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the womens health diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast cancer, increasing infertility rate in women, and increasing prevalence of STDs.
The womens health diagnostics market is segmented as below:
By Application
- Breast cancer testing
- Infectious disease testing
- STD testing
- Cervical cancer testing
- Others
By End-user
- Hospitals and clinics
- Diagnostic and imaging centers
- Home care settings
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the womens health diagnostics market covers the following areas:
- Womens health diagnostics market sizing
- Womens health diagnostics market forecast
- Womens health diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global womens health diagnostics market: Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann La Roche Ltd., FUJIFILM Corp., GE Healthcare Technologies Inc., Hologic Inc., Illumina Inc., Invitae Corp., Koninklijke Philips N.V., Myriad Genetics Inc., Natera Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Quidelortho Corp., Siemens AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is global adoption of advanced diagnostic solutions."
According to the report, one of the major drivers for this market is the increasing prevalence of breast cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Exact Sciences Corp.
- F. Hoffmann La Roche Ltd.
- FUJIFILM Corp.
- GE Healthcare Technologies Inc.
- Hologic Inc.
- Illumina Inc.
- Invitae Corp.
- Koninklijke Philips N.V.
- Myriad Genetics Inc.
- Natera Inc.
- Perkin Elmer Inc.
- QIAGEN NV
- Quest Diagnostics Inc.
- Quidelortho Corp.
- Siemens AG
- Thermo Fisher Scientific Inc.
